查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404813

肉毒桿菌毒素市场规模、份额和趋势分析报告：按产品类型、应用、最终用途、地区和细分市场预测，2024-2030 年

Botulinum Toxin Market Size, Share & Trends Analysis Report By Product Type (Type A, Type B), By Application (Therapeutic, Aesthetic), By End-use (Dermatology Clinics, Cosmetic Centers & Medspas), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

肉毒桿菌毒素市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计到2030年，全球肉毒桿菌毒素市场规模将达211亿美元，2024年至2030年复合年增长率为9.8%。

肉毒桿菌毒素是由肉毒桿菌产生的毒素所形成的药物。这些药物透过麻痹或放鬆某些肌肉或干扰某些神经来发挥作用。该药物的效果可持续数月，具体取决于治疗方法。肉毒桿菌毒素可用于治疗和美容。这种药物现在广泛用于整容手术。例如，肉毒桿菌是一种非侵入性美容手术，用于减少额头皱纹、脸部细纹、皱纹、鱼尾纹等。由于对微创或非侵入性整容手术的需求不断增长，预计在预测期内对肉毒桿菌毒素的需求将会增长。此外，不断增加的治疗应用以及不断增加的研发倡议预计将扩大市场。

40岁以上人群注重自己的身体特征，希望拥有年轻的外表。因此，女性注重美容（例如唇部护理）的趋势不断增长，尤其是在已开发国家，预计将刺激该行业的成长。肉毒桿菌毒素也用于治疗多种与老龄化相关的病症，例如鱼尾纹、鱼尾纹和额头皱纹。因此，40岁以上的人更容易出现此类老化征兆。因此，肉毒桿菌治疗在40-55岁的人群中越来越受欢迎，促进了该行业的成长。此外，偏头痛和颈部肌张力不全症等慢性疾病病例的增加也可能推动市场。

COVID-19 的疫情对市场产生了重大影响。最初，由于大多数国家的停工和全球限制，许多美容治疗和手术被取消。 COVID-19大流行对整个医疗产业的供应链造成了严重破坏。然而，由于疫情期间需求增加，肉毒桿菌（如肉毒桿菌）的销售量激增。多名整形外科医生和皮肤科医生已经证明，这种热潮适合那些希望在参加线上会议和会议时展现最佳状态并有更多时间从预约和手术中恢復的个人。

肉毒桿菌毒素市场报告亮点

  • 2023年，A类产品类型主导市场。这是因为包括Dysport和 Botox 在内的 A 型产品在大多数国家都有市售，并且经过临床测试，证明长期安全有效，副作用很少。
  • 治疗应用领域占43.0%的市场占有率。
  • 由于美容治疗技术的不断进步以及医疗专家和服务供应商数量的增加，2023年北美在全球市场中的收益占有率将占46.9%以上。
  • 由于患者人数不断增长、美容手术意识不断提高以及技术快速进步，亚太地区预计在预测期内复合年增长率最高，达到 11.1%。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章肉毒桿菌毒素市场：变数、趋势和范围

  • 市场区隔和范围
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 肉毒桿菌：市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
  • COVID-19感染疾病的影响分析

第四章肉毒桿菌毒素市场：产品类型細項分析

  • 肉毒桿菌毒素：2023 年和 2030 年产品类型市场占有率分析
  • A型
  • B型

第五章肉毒桿菌毒素市场：应用細項分析

  • 肉毒桿菌毒素：2023 年和 2030 年应用市场占有率分析
  • 治疗
  • 美丽

第六章肉毒桿菌毒素市场：最终用途細項分析

  • 肉毒桿菌毒素：2023 年和 2030 年最终用途市场占有率分析
  • 医院
  • 皮肤科诊所
  • 水疗及美容中心

第七章肉毒桿菌毒素市场：区域分析

  • 肉毒桿菌毒素：2023 年和 2030 年区域市场占有率分析
  • 北美洲
    • 北美肉毒桿菌毒素市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲肉毒桿菌毒素市场，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太肉毒桿菌毒素市场，2018-2030
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲肉毒桿菌毒素市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • MEA 肉毒桿菌毒素市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 公司简介

  • 主要市场参与企业的最新趋势和影响分析
  • 肉毒桿菌毒素 -市场占有率分析
  • Ipsen Group
    • 公司简介
    • 财务绩效
    • 产品基准评效
    • 策略倡议
  • Allergen Inc.
    • 公司简介
    • 财务绩效
    • 产品基准评效
    • 策略倡议
  • Medy-Tox, Inc.
    • 公司简介
    • 财务绩效
    • 产品基准评效
    • 策略倡议
  • Metabiologics
    • 公司简介
    • 财务绩效
    • 策略倡议
  • Merz Pharma
    • 公司简介
    • 财务绩效
    • 产品基准评效
    • 策略倡议
  • US Worldmeds
    • 公司简介
    • 财务绩效
    • 产品基准评效
    • 策略倡议
  • Evolus
    • 公司简介
    • 财务绩效
    • 产品基准评效
    • 策略倡议
  • Galderma
    • 公司简介
    • 财务绩效
    • 产品基准评效
    • 策略倡议
  • Lanzhou Institute Of Biological Products
    • 公司简介
    • 财务绩效
    • 产品基准评效
    • 策略倡议
Product Code: GVR-1-68038-355-3

Botulinum Toxin Market Growth & Trends:

The global botulinum toxin market size is expected to reach USD 21.1 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 9.8% from 2024 to 2030. Botulinum toxin is a drug formed from a toxin built by the bacteria clostridium botulinum. These drugs work by paralyzing or tempering specific muscles or by hindering certain nerves. The effect of the drug lasts for about a few months, depending on the treatment. Botulinum toxin is used for both therapeutic and aesthetic applications. Nowadays, the drug is highly adopted for aesthetic procedures. For instance, Botox is a non-invasive cosmetic procedure and is used to reduce forehead creases, facial fine lines, wrinkles, and crow's feet among others. The demand for botulinum toxin is expected to grow during the forecast period owing to the growing demand for minimally invasive or non-invasive procedures in aesthetics. Furthermore, increasing application in therapeutic applications, coupled with growing R&D initiatives, is expected to expand the market.

Population aged above 40 years are focusing on the physical features and wish to have a younger look. Thus, rising emphasis on aesthetic beauty, for instance, lip treatments by women, especially in developed countries is anticipated to fuel the industry growth. Also, botulinum toxin is used to treat several age-related conditions such as glabellar lines, crow's feet, and forehead lines. Hence, people above the age of 40 are more vulnerable to such signs of aging. Therefore, procedures of botulinum toxin are gaining more popularity among individuals aged between 40-55 years, thereby augmenting the industry growth. Furthermore, rising cases of chronic disorders such as migraine and cervical dystonia are likely to drive the market.

The COVID-19 outbreak has significantly affected the market. Initially, due to lockdown and global restrictions being imposed in most countries, many aesthetic treatments and procedures were halted. The COVID-19 pandemic has caused a huge disruption in the supply chain of the overall medical industry. However, the sales of botulinum toxins such as botox observed a surge due to the increased demand during the pandemic. Several plastic surgeons and dermatologists are accrediting the boom to individuals wishing to put their finest appearance for online meetings and conferences and greater time to attend consultations and recover from procedures.

Botulinum Toxin Market Report Highlights:

  • The type A product type segment dominated the market in 2023. This is because type A products including Dysport and Botox are commercially available in the market in most countries and have been clinically tested and proven to be safe and effective in the long term with minimal side effects.
  • The therapeutic application segment accounted for 43.0% of the market share
  • North America dominated the global market in 2023 with a revenue share of over 46.9% owing to the rising technological advancements for cosmetic treatments and the increasing number of specialists and service providers
  • Asia Pacific is expected to register the highest CAGR of 11.1% over the forecast period owing to the growing patient population, rising awareness regarding aesthetic procedures, and rapid technological advancements

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Product Type
    • 1.1.2 Application
    • 1.1.3 End-Use
    • 1.1.4 Regional Scope
    • 1.1.5 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
  • 1.7 List Of Secondary Sources
  • 1.8 List Of Primary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective - 1
    • 1.10.2 Objective - 2
    • 1.10.3 Objective - 3

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Botulinum Toxin Market: Variables, Trends, & Scope

  • 3.1 Market Segmentation And Scope
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.2.1 Increasing Number Of Patients Having Neurological Disorders
      • 3.2.2.2 Rising Preference For Non-Invasive Or Minimally Invasive Procedures
      • 3.2.2.3 Increasing Concern Regarding Aesthetic Appearance In 40-54 Age Group Has Increased The Adoption Rate
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High Cost Of Cosmetic Procedure
  • 3.3 Botulinum Toxin: Market Analysis Tools
    • 3.3.1 Industry Analysis - Porter's
    • 3.3.2 Pestel Analysis
  • 3.4 COVID-19 Impact Analysis

Chapter 4 Botulinum Toxin Market: Product Type Segment Analysis

  • 4.1 Botulinum Toxin: Product Type Market Share Analysis, 2023 & 2030
  • 4.2 Type A
    • 4.2.1 Type A Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
      • 4.2.1.1 Botox
      • 4.2.1.2 Dysport
      • 4.2.1.3 Xeomin
      • 4.2.1.4 Others
    • 4.2.2 Type B
      • 4.2.2.1 Type B Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 5 Botulinum Toxin Market: Application Segment Analysis

  • 5.1 Botulinum Toxin: Application Market Share Analysis, 2023 & 2030
  • 5.2 Therapeutic
    • 5.2.1 Therapeutic Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
      • 5.2.1.1 Chronic Migraine
      • 5.2.1.2 Overactive Bladder
      • 5.2.1.3 Cervical Dystonia
      • 5.2.1.4 Spasticity
      • 5.2.1.5 Others
  • 5.3 Aesthetic
    • 5.3.1 Aesthetic Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
      • 5.3.1.1 Glabellar Lines
      • 5.3.1.2 Crow's Feet
      • 5.3.1.3 Forehead Lines
      • 5.3.1.4 Others

Chapter 6 Botulinum Toxin Market: End-Use Segment Analysis

  • 6.1 Botulinum Toxin: End-Use Market Share Analysis, 2023 & 2030
  • 6.2 Hospitals
    • 6.2.1 Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.3 Dermatology Clinics
    • 6.3.1 Dermatology Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.4 Spas And Cosmetic Centers
    • 6.4.1 Spas And Cosmetic Centers Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7 Botulinum Toxin Market: Regional Analysis

  • 7.1 Botulinum Toxin: Regional Market Share Analysis, 2023 & 2030
  • 7.2 North America
    • 7.2.1 North America Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.2.2 U.S.
      • 7.2.2.1 Key Country Dynamics
      • 7.2.2.2 U.S. Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.2.3 Canada
      • 7.2.3.1 Key Country Dynamics
      • 7.2.3.2 Canada Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  • 7.3 Europe
    • 7.3.1 Europe Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.3.2 UK
      • 7.3.2.1 Key Country Dynamics
      • 7.3.2.2 UK Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.3.3 Germany
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Germany Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.3.4 France
      • 7.3.4.1 Key Country Dynamics
      • 7.3.4.2 France Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.3.5 Italy
      • 7.3.5.1 Key Country Dynamics
      • 7.3.5.2 Italy Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.3.6 Spain
      • 7.3.6.1 Key Country Dynamics
      • 7.3.6.2 Spain Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.3.7 Denmark
      • 7.3.7.1 Key Country Dynamics
      • 7.3.7.2 Denmark Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.3.8 Sweden
      • 7.3.8.1 Key Country Dynamics
      • 7.3.8.2 Sweden Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.3.9 Norway
      • 7.3.9.1 Key Country Dynamics
      • 7.3.9.2 Norway Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.4.2 China
      • 7.4.2.1 Key Country Dynamics
      • 7.4.2.2 China Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.4.3 India
      • 7.4.3.1 Key Country Dynamics
      • 7.4.3.2 India Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.4.4 Japan
      • 7.4.4.1 Key Country Dynamics
      • 7.4.4.2 Japan Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.4.5 South Korea
      • 7.4.5.1 Key Country Dynamics
      • 7.4.5.2 South Korea Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.4.6 Australia
      • 7.4.6.1 Key Country Dynamics
      • 7.4.6.2 Australia Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.4.7 Thailand
      • 7.4.7.1 Key Country Dynamics
      • 7.4.7.2 Thailand Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  • 7.5 Latin America
    • 7.5.1 Latin America Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.5.2 Brazil
      • 7.5.2.1 Key Country Dynamics
      • 7.5.2.2 Brazil Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.5.3 Mexico
      • 7.5.3.1 Key Country Dynamics
      • 7.5.3.2 Mexico Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.5.4 Argentina
      • 7.6.4.1 Key Country Dynamics
      • 7.6.4.2 Argentina Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  • 7.6 MEA
    • 7.6.1 MEA Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.6.2 South Africa
      • 7.6.2.1 Key Country Dynamics
      • 7.6.2.2 South Africa Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Key Country Dynamics
      • 7.6.3.2 Saudi Arabia Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.6.4 UAE
      • 7.6.4.1 Key Country Dynamics
      • 7.6.4.2 UAE Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.6.5 Kuwait
      • 7.6.5.1 Key Country Dynamics
      • 7.6.5.2 Kuwait Botulinum Toxin Market, 2018 - 2030 (USD Billion)

Chapter 8 Company Profiles

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Botulinum Toxin- Market Share Analysis
  • 8.3. Ipsen Group
    • 8.3.1 Company Overview
    • 8.3.2 Financial Performance
    • 8.3.3 Product Benchmarking
    • 8.3.4 Strategic Initiatives
  • 8.4. Allergen Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Performance
    • 8.4.3 Product Benchmarking
    • 8.4.4 Strategic Initiatives
  • 8.5 Medy-Tox, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Performance
    • 8.5.3 Product Benchmarking
    • 8.5.4 Strategic Initiatives
  • 8.6 Metabiologics
    • 8.6.1 Company Overview
    • 8.6.2 Financial Performance
    • 8.6.3 Strategic Initiatives
  • 8.7 Merz Pharma
    • 8.7.1 Company Overview
    • 8.7.2 Financial Performance
    • 8.7.3 Product Benchmarking
    • 8.7.4 Strategic Initiatives
  • 8.8 US Worldmeds
    • 8.8.1 Company Overview
    • 8.8.2 Financial Performance
    • 8.8.3 Product Benchmarking
    • 8.8.4 Strategic Initiatives
  • 8.9 Evolus
    • 8.9.1 Company Overview
    • 8.9.2 Financial Performance
    • 8.9.3 Product Benchmarking
    • 8.9.4 Strategic Initiatives
  • 8.10 Galderma
    • 8.10.1 Company Overview
    • 8.10.2 Financial Performance
    • 8.10.3 Product Benchmarking
    • 8.10.4 Strategic Initiatives
  • 8.11 Lanzhou Institute Of Biological Products
    • 8.11.1 Company Overview
    • 8.11.2 Financial Performance
    • 8.11.3 Product Benchmarking
    • 8.11.4 Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 Strategic collaborations by key players

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity flow analysis
  • Fig. 9 Botulinum toxin market snapshot (2023)
  • Fig. 10 Botulinum toxin market segmentation
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's Five Forces analysis
  • Fig. 15 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 16 Botulinum toxin market product type outlook: Segment dashboard
  • Fig. 17 Botulinum toxin market: product type movement analysis
  • Fig. 18 Type A market, 2018 - 2030 (USD Billion)
  • Fig. 19 Type B market, 2018 - 2030 (USD Billion)
  • Fig. 20 Botulinum toxin market application outlook: Segment dashboard
  • Fig. 21 Botulinum toxin market: Application movement analysis
  • Fig. 22 Therapeutic market, 2018 - 2030 (USD Billion)
  • Fig. 23 Aesthetic market, 2018 - 2030 (USD Billion)
  • Fig. 24 Botulinum toxin market end-use outlook: Segment dashboard
  • Fig. 25 Botulinum toxin market: End-use movement analysis
  • Fig. 26 Hospitals market, 2018 - 2030 (USD Billion)
  • Fig. 27 Dermatology clinics market, 2018 - 2030 (USD Billion)
  • Fig. 28 Cosmetic centers and medspas market, 2018 - 2030 (USD Billion)
  • Fig. 29 Regional market: Key takeaways
  • Fig. 30 Regional outlook: 2023 & 2030
  • Fig. 31 North America market, 2018 - 2030 (USD Billion)
  • Fig. 32 U.S. market, 2018 - 2030 (USD Billion)
  • Fig. 33 Key country dynamics
  • Fig. 34 Canada market, 2018 - 2030 (USD Billion)
  • Fig. 35 Key country dynamics
  • Fig. 36 Europe market, 2018 - 2030
  • Fig. 37 UK market, 2018 - 2030 (USD Billion)
  • Fig. 38 Key country dynamics
  • Fig. 39 Germany market, 2018 - 2030 (USD Billion)
  • Fig. 40 Key country dynamics
  • Fig. 41 France market, 2018 - 2030 (USD Billion)
  • Fig. 42 Key country dynamics
  • Fig. 43 Italy market, 2018 - 2030 (USD Billion)
  • Fig. 44 Key country dynamics
  • Fig. 45 Spain market, 2018 - 2030 (USD Billion)
  • Fig. 46 Key country dynamics
  • Fig. 47 Denmark market, 2018 - 2030 (USD Billion)
  • Fig. 48 Key country dynamics
  • Fig. 49 Sweden market, 2018 - 2030 (USD Billion)
  • Fig. 50 Key country dynamics
  • Fig. 51 Norway market, 2018 - 2030 (USD Billion)
  • Fig. 52 Key country dynamics
  • Fig. 53 Asia Pacific market, 2018 - 2030 (USD Billion)
  • Fig. 54 China market, 2018 - 2030 (USD Billion)
  • Fig. 55 Key country dynamics
  • Fig. 56 Japan market, 2018 - 2030 (USD Billion)
  • Fig. 57 Key country dynamics
  • Fig. 58 India market, 2018 - 2030 (USD Billion)
  • Fig. 59 Key country dynamics
  • Fig. 60 South Korea market, 2018 - 2030 (USD Billion)
  • Fig. 61 Key country dynamics
  • Fig. 62 Australia market, 2018 - 2030 (USD Billion)
  • Fig. 63 Key country dynamics
  • Fig. 64 Thailand market, 2018 - 2030 (USD Billion)
  • Fig. 65 Key country dynamics
  • Fig. 66 Latin America market, 2018 - 2030 (USD Billion)
  • Fig. 67 Brazil market, 2018 - 2030 (USD Billion)
  • Fig. 68 Key country dynamics
  • Fig. 69 Mexico market, 2018 - 2030 (USD Billion)
  • Fig. 70 Key country dynamics
  • Fig. 71 Argentina market, 2018 - 2030 (USD Billion)
  • Fig. 72 Key country dynamics
  • Fig. 73 MEA market, 2018 - 2030 (USD Billion)
  • Fig. 74 South Africa market, 2018 - 2030 (USD Billion)
  • Fig. 75 Key country dynamics
  • Fig. 76 Saudi Arabia market, 2018 - 2030 (USD Billion)
  • Fig. 77 Key country dynamics
  • Fig. 78 UAE market, 2018 - 2030 (USD Billion)
  • Fig. 79 Key country dynamics
  • Fig. 80 Kuwait market, 2018 - 2030 (USD Billion)
  • Fig. 81 Key country dynamics